ERD

eTRANSAFE | Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management

01-09-2017

-

28-02-2023

Show more information

Organisation NOVARTIS PHARMA AG

TransBioLine | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

01-02-2019

-

31-01-2025

Show more information

Organisation NOVARTIS PHARMA AG

IM2PACT | Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain

01-01-2019

-

31-12-2024

Show more information

Organisation NOVARTIS PHARMA AG

ROADMAP | Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020

01-11-2016

-

31-10-2018

Show more information

Organisation NOVARTIS PHARMA AG

EPND | European platform for neurodegenerative disorders

01-11-2021

-

31-10-2026

Show more information

Organisation NOVARTIS PHARMA AG

PREMIER | Prioritisation and Risk Evaluation of Medicines in the EnviRonment

01-09-2020

-

31-08-2026

Show more information

Organisation NOVARTIS PHARMA AG

EQIPD | European Quality In Preclinical Data

01-10-2017

-

30-09-2021

Show more information

Organisation NOVARTIS PHARMA AG

FAIRplus | FAIRplus

01-01-2019

-

31-12-2022

Show more information

Organisation NOVARTIS PHARMA AG

imSAVAR | Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

01-12-2019

-

30-11-2025

Show more information

Organisation NOVARTIS PHARMA AG

Immune-Image | Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies

01-10-2019

-

31-03-2026

Show more information

Organisation NOVARTIS PHARMA AG

IMPACTIVE | Innovative Mechanochemical Processes to synthesize green ACTIVE pharmaceutical ingredients.

01-10-2022

-

30-09-2026

Show more information

Organisation NOVARTIS PHARMA AG

PRISM | Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916

01-04-2016

-

30-09-2019

Show more information

Organisation NOVARTIS PHARMA AG

MACUSTAR | Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076

01-09-2017

-

31-05-2024

Show more information

Organisation NOVARTIS PHARMA AG

H2O | H2O Health Outcomes Observatory

01-10-2020

-

30-09-2025

Show more information

Organisation NOVARTIS PHARMA AG

EHDEN | European Health Data and Evidence Network

01-11-2018

-

31-10-2024

Show more information

Organisation NOVARTIS PHARMA AG

AEGIS | Accelerated Early staGe drug diScovery

01-01-2016

-

31-12-2019

Show more information

Organisation NOVARTIS PHARMA AG

IMPRiND | Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060

01-03-2017

-

28-02-2022

Show more information

Organisation NOVARTIS PHARMA AG

BigData Heart | Big Data 4 Better Hearts - Sofia ref.: 116074

01-03-2017

-

28-02-2023

Show more information

Organisation NOVARTIS PHARMA AG

UbiCODE | European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets

01-01-2018

-

31-12-2022

Show more information

Organisation Novartis

MetRaZymes | Metal-containing Radical Enzymes

01-10-2022

-

30-09-2026

Show more information

Organisation NOVARTIS PHARMA AG

INVENTS | Innovative designs, extrapolation, simulation methods and evidence-tools for rare diseases addressing regulatory needs

01-01-2024

-

31-12-2028

Show more information

Organisation NOVARTIS PHARMA AG

CaSR Biomedicine | Calcium-Sensing Receptor (CaSR): Therapeutics for Non-Communicable Diseases

01-03-2016

-

29-02-2020

Show more information

Organisation NOVARTIS PHARMA AG

NeuroDeRisk | Neurotoxicity De-Risking in Preclinical Drug Discovery

01-03-2019

-

30-09-2022

Show more information

Organisation NOVARTIS PHARMA AG

RADAR-AD | Remote Assessment of Disease and Relapse – Alzheimer’s Disease

01-01-2019

-

30-06-2023

Show more information

Organisation NOVARTIS PHARMA AG

CHESS | Connected Health Early Stage Researcher Support System

01-09-2015

-

31-08-2019

Show more information

Organisation NOVARTIS PHARMA AG

CHAIR | C-H Activation for Industrial Renewal

01-07-2020

-

31-12-2024

Show more information

Organisation NOVARTIS PHARMA AG

PSI-FELLOW-II-3i | International, Interdisciplinary and Intersectoral Postdocs

01-10-2016

-

30-09-2021

Show more information

Organisation NOVARTIS INTERNATIONAL AG

MEL-PLEX | Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine

01-12-2014

-

30-11-2018

Show more information

Organisation NOVARTIS PHARMA GMBH

WEB-RADR 2 | WEB-RADR 2

01-09-2018

-

30-06-2020

Show more information

Organisation NOVARTIS PHARMA AG

ReSOLUTE | Research empowerment on solute carriers (ReSOLUTE)

01-07-2018

-

31-12-2023

Show more information

Organisation NOVARTIS PHARMA AG

Projects overview

Selected filters:

eTRANSAFE | Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management

TransBioLine | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease

IM2PACT | Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain

ROADMAP | Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020

EPND | European platform for neurodegenerative disorders

PREMIER | Prioritisation and Risk Evaluation of Medicines in the EnviRonment

EQIPD | European Quality In Preclinical Data

FAIRplus | FAIRplus

imSAVAR | Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Immune-Image | Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies

IMPACTIVE | Innovative Mechanochemical Processes to synthesize green ACTIVE pharmaceutical ingredients.

PRISM | Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916

MACUSTAR | Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076

H2O | H2O Health Outcomes Observatory

EHDEN | European Health Data and Evidence Network

AEGIS | Accelerated Early staGe drug diScovery

IMPRiND | Inhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060

BigData Heart | Big Data 4 Better Hearts - Sofia ref.: 116074

UbiCODE | European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets

MetRaZymes | Metal-containing Radical Enzymes

INVENTS | Innovative designs, extrapolation, simulation methods and evidence-tools for rare diseases addressing regulatory needs

CaSR Biomedicine | Calcium-Sensing Receptor (CaSR): Therapeutics for Non-Communicable Diseases

NeuroDeRisk | Neurotoxicity De-Risking in Preclinical Drug Discovery

RADAR-AD | Remote Assessment of Disease and Relapse – Alzheimer’s Disease

CHESS | Connected Health Early Stage Researcher Support System

CHAIR | C-H Activation for Industrial Renewal

PSI-FELLOW-II-3i | International, Interdisciplinary and Intersectoral Postdocs

MEL-PLEX | Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine

WEB-RADR 2 | WEB-RADR 2

ReSOLUTE | Research empowerment on solute carriers (ReSOLUTE)